| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2K | +0.0% |
| SG&A Expense | $97K | -36.8% |
| Operating Income | -$97K | +58.1% |
| Pre-tax Income | -$100K | +87.5% |
| Net Income | -$100K | +87.5% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $21K | +746.6% |
| Total Assets | $21K | +746.6% |
| Current Liabilities | $44K | -91.6% |
| Total Liabilities | $44K | -91.6% |
| Stockholders' Equity | -$23K | +95.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89K | -16.8% |
| Financing Cash Flow | $101K | +1004.4% |